The Vanguard Group's Disclosure on Spire Healthcare Group Investment

The Vanguard Group, Inc. has disclosed its stake in Spire Healthcare Group plc, as mandated by Rule 8.3 of the Takeover Code. As of October 19, 2026, Vanguard owns and controls 14,439,595 shares, representing 3.59% of Spire's ordinary 1p shares. No additional parties or cash offers are connected to this disclosure.

During the reported period, Vanguard executed transactions involving Spire's securities. It purchased 858 ordinary shares at 2.47 GBP each and sold 1,095 shares at the same price. Currently, Vanguard has no open cash-settled or stock-settled derivatives related to Spire.

No indemnity agreements, arrangements involving options or derivatives, or other understandings related to Spire were reported. Additionally, no Supplemental Form 8 was attached to this disclosure, indicating no open positions to report.